Introduction
In recent years, at-home DNA testing has transformed from a niche scientific curiosity into a mainstream consumer product. Millions of people around the world have mailed a small tube of saliva to a laboratory and waited eagerly for reports about their ancestry, health risks, and genetic traits. At the center of this revolution stands 23andMe — one of the most recognized names in direct-to-consumer genetic testing, founded in 2006 and based in California.
But how accurate is the 23andMe DNA test, really? Can you trust what it tells you about your heritage? Should you make health decisions based on its reports? These are important questions that deserve honest, thorough answers. The truth, as with most things in science, is nuanced — and understanding the difference between what 23andMe does well and where it falls short could save you from both unrealistic expectations and potential misunderstandings.
How Does 23andMe Actually Work?
Before evaluating accuracy, it helps to understand the technology behind the test. When you purchase a 23andMe kit, you receive a collection tube in which you deposit a saliva sample. That sample is mailed back to the lab, where scientists extract your DNA and use a process called genotyping to analyze it.
Genotyping does not read your entire genome. Instead, it looks at hundreds of thousands of specific locations in your DNA — called single nucleotide polymorphisms (SNPs) — that are known to vary between people. Genotyping reads only about 0.1% of your genome, which means the data identified and interpreted is inherently incomplete. This is a critical point that many users do not fully appreciate when they first receive their results. Nucleus
Once your genotype is established, 23andMe’s algorithms compare your genetic data to reference populations and databases to generate reports on ancestry composition, health risks, carrier status, and traits.
Ancestry Accuracy: The Strongest Part of the Test
For most people, ancestry is the primary reason they take a DNA test, and this is also the area where 23andMe performs most reliably.
The 23andMe Ancestry Composition Report provides an estimate of your ancestry breakdown by comparing your DNA to the DNA of more than 15 million people from around the world. With one of the largest reference datasets in the world, 23andMe provides customers with one of the most detailed and accurate ancestry breakdowns on the market. The Ancestry Composition analysis works by dividing your genome into thousands of segments and then estimating the ancestry of each segment based on which global population it most closely matches. 23andMe
Precision values for the vast majority of populations are greater than 90%, indicating high accuracy when the company is confident in its ability to predict a piece of DNA as coming from one of their reference populations. 23andMe
In 2025, the company made significant improvements to its ancestry tools. The most significant update ever to the Ancestry Composition report expanded granularity and increased accuracy across the globe. Members can now see if they have connections to more than 4,500 geographic regions — the most comprehensive ancestry breakdown on the market. Ancestry Composition v7.0 was a major overhaul, adding 33 new European populations and 6 new Indigenous American populations, and thanks to a new DNA phasing pipeline and a new method for refining reference panels, the update also improved accuracy for other regions of the world. 23andMe
However, ancestry accuracy is not equal across all populations. Results for people of European descent tend to be the most precise because European populations are heavily represented in reference databases. People of African, South Asian, Middle Eastern, or Indigenous American ancestry may find their results less granular or less precise, simply because those populations are underrepresented in the reference panel.
There is also the challenge of small percentage readings. The accuracy of 23andMe DNA tests is generally high for major ancestry categories such as European, African, and Asian, often exceeding 90%. However, when it comes to smaller percentages, particularly those below 5%, accuracy can decrease significantly. A 2% reading for a particular ancestry should be treated as suggestive rather than definitive. Quora
The countries and groups shown in results are not based on how well you resemble a reference population, but on how you actually match with specific members of that reference population. The more people you match, and the more DNA you share with those specific people, the higher confidence 23andMe has in your connection to that place. Confidence is rated as “possible,” “likely,” or “highly likely.” Your DNA Guide
Health Report Accuracy: Where Things Get More Complicated
The health side of 23andMe is where accuracy becomes a more complicated and controversial subject. The company offers several types of health-related reports, each with different levels of reliability.
Genetic Health Risk Reports
The Genetic Health Risk and Carrier Status Reports meet FDA requirements. Each variant in these reports demonstrated greater than 99% accuracy, and each variant also showed greater than 99% reproducibility when tested under different laboratory conditions. 23andMe
That sounds impressive — and it is, in terms of the raw technical measurement of your DNA. But here is where many people misunderstand what these reports actually mean.
According to one expert, the accuracy of the test itself is not the biggest issue. A greater problem is that the results provide “a very incomplete view” of a person’s risk for a given disease, said Amy Sturm, a genetic counselor at The Ohio State University Wexner Medical Center. Live Science
This is because 23andMe tests for a limited set of genetic variants associated with any given condition — not all possible variants. None of the genes associated with health conditions are comprehensively sequenced or analyzed in DTC tests. For example, 23andMe’s genetic health risk test reports on just one variant in each of two genes linked to Parkinson’s disease: LRRK2 and GBA. However, there are additional known pathogenic variants in these two genes as well as additional genes clinically associated with Parkinson’s disease that 23andMe does not report on. Therefore, the consumer is not provided with a comprehensive genetic risk assessment. PubMed Central
This means that a negative result does not mean you are in the clear. You might carry a disease-associated variant that 23andMe simply does not test for.
The BRCA Gene Problem
One of the most alarming examples of this limitation involves the BRCA1 and BRCA2 genes, which are linked to higher risks of breast and ovarian cancer. A 2019 study found that nearly 90% of participants who carried a BRCA mutation would have been missed by 23andMe’s test. This is a sobering statistic. A person could receive a negative 23andMe result for BRCA variants and wrongly conclude they are not at elevated cancer risk, when in fact they carry a variant the test did not screen for. The Conversation
Wellness and Trait Reports
Wellness Reports explore how DNA can influence lifestyle factors like diet, exercise, and sleep. Some of these reports are based on specific genetic variants that have support from the scientific literature, but these reports have not been clinically validated. 23andMe
This means they are interesting as exploratory insights but should not be used to make major lifestyle or medical decisions without consulting a healthcare professional.
What Experts Say: “Entertainment Genetics”
Some scientists are blunter in their assessment of consumer DNA tests. Dr. Chris Carlson, a geneticist at Fred Hutch’s Public Health Sciences Division, describes 23andMe’s value as more “entertainment genetics.” A personal genetic test will probably give more useful information about a person’s ancestry than their health. “As geneticists, we want people to be excited about genetics, but most people could get more information about their health risks by looking at their family tree.” Fred Hutchinson Cancer Center
23andMe draws from studies linking specific genetic variants with increased disease risk, but such reports need to be meticulously validated before being used in any diagnostic capacity. In epidemiological studies, the false positive rate can be very high, with less than one percent of such reports validated in further tests. Fred Hutchinson Cancer Center
DNA Relative Matching: Generally Reliable for Close Relatives
One feature that tends to be quite reliable is DNA Relative Matching — the ability to find people who share significant amounts of DNA with you. Close relatives such as parents, siblings, and first cousins share large amounts of DNA that are easy to detect with high confidence.
The predicted relationship between two matches is an estimate based on how much DNA is shared. However, the prediction shown represents one of many possible genealogical relationships that would result in about the same amount of shared DNA — including half- and removed relationships. Your DNA Guide
So while the DNA match itself is accurate, the predicted relationship label (e.g., “2nd cousin”) is an educated estimate and could reflect several different actual relationships.
Privacy and Data Security Concerns
Accuracy is not the only issue worth considering. Individuals have expressed concern about “feeling naked and exposed” in light of 23andMe’s struggles, leading some experts to urge customers to withdraw their consent and delete their accounts as an additional precaution. The Conversation
The 23andMe database also has limitations in that health data are almost entirely self-reported, whereas other similar collections such as the UK Biobank contain information from electronic health records. Palmerlab
Companies like 23andMe require users to opt in to have their data used in licensing agreements with other businesses. In one notable case, 23andMe was paid $20 million to let pharmaceutical company GSK conduct drug target discovery and other research using the 23andMe database. Additionally, in the case of a merger or acquisition, 23andMe’s repository of customer information could be sold as a valuable asset. The Conversation
These are legitimate concerns that go beyond accuracy — they touch on what happens to your most personal data after the test is done.
How Does 23andMe Compare to Clinical Genetic Testing?
It is important to understand that 23andMe is a direct-to-consumer product, not a clinical diagnostic tool. Clinical genetic tests ordered by a doctor are far more comprehensive, cover many more variants, and come with professional interpretation and genetic counseling. A common misconception among users is that 23andMe’s health reports are FDA-approved. However, the platform clarifies that only some of its reports meet FDA requirements for clinical validity. Nucleus
If you have a genuine medical concern — such as a strong family history of cancer, heart disease, or a hereditary condition — you should speak with your doctor and request proper clinical genetic testing, not rely on a consumer DNA kit.
The Bottom Line: What Can You Trust?
Here is a fair summary of where 23andMe’s accuracy stands:
High Accuracy:
- Raw DNA genotyping (the lab process of reading your DNA variants)
- Major ancestry categories — European, African, Asian — typically above 90% precision
- Carrier status and health risk reports for specific, FDA-reviewed variants (greater than 99% for tested variants)
- Close DNA relative matching
Moderate Accuracy:
- Regional ancestry breakdown within continents
- Country and genetic group assignments (rated with confidence levels)
- Predicted relationship labels for DNA matches
Limited Accuracy or Incomplete:
- Small ancestry percentages below 5%
- Health risk reports for complex diseases — these cover only a fraction of relevant variants
- BRCA and other cancer-risk gene testing — misses the majority of real mutations
- Wellness and trait reports — not clinically validated
Final Verdict
23andMe is a fascinating product that can offer genuine insights — particularly about broad ancestry origins and connecting with potential relatives. Its laboratory methods are technically sound, and the company’s algorithms make ancestry estimates based on probabilities and are generally very accurate, though results are not set in stone as the company is always trying to improve and refine these estimates. 23andMe
However, the test has real limitations that users must understand. It reads less than 1% of your genome. Its health reports are incomplete by design. A negative result for a disease risk does not mean you are safe. And the data you share is permanent and valuable to third parties.
Used with the right expectations — as an exploratory tool for ancestry curiosity and a starting point for genetic awareness — 23andMe can be worthwhile. Used as a substitute for proper medical advice, it can be misleading or even harmful.
The wisest approach: enjoy what 23andMe tells you about your heritage, but always consult a qualified healthcare professional before drawing any serious medical conclusions from its health reports.